$123.82
+1.56 (+1.28%)
As of Feb 24, 1:03 PM ET ·
Analyst Consensus
Buy
34
Analysts
Very High
Coverage
Buy 21 62%
Hold 13 38%
Sell 0 0%
Price Target
Analyst Price Target +28.6% upside
Low Target $113.44
Average Target $159.27
High Target $183.82
Current Price $123.82
Current
$123.82
Target
$159.27
$113.44 $159.27 avg $183.82
Scenario Analysis
Bear Case
$113.44
-8.4%
Low target
Base Case
$159.27
+28.6%
Avg target
Bull Case
$183.82
+48.5%
High target
Risk/Reward
5.8x
Highly favorable
Price in Context
52-Week High
$123.33
0.4% from high
52-Week Low
$73.31
+68.9% from low
50-Day SMA
$109.24
+13.3% vs SMA
200-Day SMA
$90.33
+37.1% vs SMA
RSI (14)
79.1
Overbought
Target vs 52W High
$159.27
+29.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
Buy 18 61% $122.82 +670.0%